Last reviewed: June 3, 2026
Last updated: June 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss benefits in multiple clinical studies. Research shows patients using semaglutide lose substantially more weight than with diet and exercise alone, with some losing over 20 pounds in 12 months. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, serving all 50 states without insurance requirements.
How Semaglutide Works for Weight Loss
Semaglutide mimics GLP-1, a natural hormone that controls appetite and blood sugar. When semaglutide binds to GLP-1 receptors in your brain's appetite centers, it sends signals that you feel full faster and stay satisfied longer between meals. This mechanism reduces calorie intake without requiring extreme willpower or restrictive dieting, making sustainable weight loss more achievable.
The medication also slows gastric emptying, meaning food stays in your stomach longer and digests more gradually. This extended fullness sensation helps prevent overeating and reduces cravings for high-calorie foods. Additionally, semaglutide may increase your resting metabolic rate slightly, meaning your body burns more calories at rest throughout the day.
Clinical Evidence of Semaglutide Weight Loss Results
The STEP trial program, which followed over 4,500 patients for 68 weeks, showed that those taking semaglutide lost an average of 15.3 kg (approximately 34 pounds) compared to 2.6 kg (6 pounds) in the placebo group. Participants receiving the highest doses achieved weight loss of approximately 22% of their starting body weight, representing one of the most significant pharmaceutical weight loss interventions studied. These results held across diverse populations including those with and without diabetes.
Long-term data from 2-year follow-up studies demonstrates that weight loss is sustained as long as patients continue treatment. Studies show that patients who stop semaglutide typically regain weight gradually, emphasizing that ongoing use maintains benefits. The consistency of results across different patient demographics indicates that semaglutide works effectively regardless of age, gender, or baseline metabolic health.
Semaglutide Dose Progression and How PlexusDx Pricing Works
Semaglutide treatment typically starts at a lower dose (0.25 mg weekly) and increases gradually every 4 weeks over several months until reaching the therapeutic dose of 2.4 mg weekly. This gradual escalation allows your body to adapt, reduces nausea risk, and helps identify your optimal personal dose. Many patients achieve significant weight loss at intermediate doses and do not need to reach the maximum dose.
PlexusDx charges a flat monthly rate that does not increase as your dose increases—your dose may need to go up, but your price won't. Compounded semaglutide injection starts at $149 per month across all commitment tiers, providing transparent, predictable costs regardless of how your therapy evolves. This pricing model removes hidden costs and ensures you know your exact monthly investment in your weight loss journey.
Personalized Semaglutide Therapy with PlexusDx Genetic Testing
Not everyone responds identically to semaglutide; individual genetic variation in GLP-1 receptor structure and sensitivity influences both how effectively the medication works and which side effects you might experience. PlexusDx offers the Precision Peptide Genetic Test, which analyzes your variants in GLP1R (rs6923761), GIPR, FTO, and MC4R genes across 14 metabolic pathways to predict your individual response profile. Understanding your genetic predispositions helps your care team personalize dosing strategy and anticipate tolerance development.
The Precision Peptide Genetic Test becomes available as a $99 add-on after your first month of treatment, giving your PlexusDx provider precise data about your unique peptide pathway sensitivities. This genetic insight allows optimization of your semaglutide dose progression and helps identify whether additional therapies or compounds might enhance your personal results. Genetic personalization transforms weight loss from a one-size-fits-all approach into truly individualized medicine.
Common Side Effects and Safety Considerations
The most frequently reported side effects include nausea, vomiting, diarrhea, and constipation, typically most noticeable during the first 4-8 weeks and during dose increases. These gastrointestinal effects usually diminish as your body adjusts, though some patients manage them with antiemetic medications or dietary modifications. More serious but rare side effects include pancreatitis symptoms (severe abdominal pain), gallbladder issues, and thyroid concerns, which require immediate medical attention.
Semaglutide is not recommended for patients with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or who are pregnant or planning pregnancy. The medication is sourced from licensed 503A compounding pharmacies that maintain pharmaceutical-grade sterility and potency standards. PlexusDx provides comprehensive patient education and monitoring protocols to ensure safe and effective treatment throughout your weight loss journey.
Semaglutide Injection vs. Oral Semaglutide: Which Is Right for You
Injected semaglutide is administered once weekly under the skin (subcutaneously) and achieves peak blood levels consistently, making dosing predictable and reliable for most patients. Oral semaglutide tablets are taken daily but require specific administration instructions—fasting stomach, waiting 30 minutes before eating—which some patients find inconvenient. Injection therapy typically shows faster weight loss results because injectable semaglutide reaches higher blood concentrations than oral formulations.
PlexusDx offers compounded semaglutide injection starting at $149 per month and oral semaglutide at $249 per month, allowing you to choose based on personal preference and lifestyle. Many patients prefer the once-weekly injection schedule and superior pharmacokinetics, while others prefer the convenience of daily oral dosing. Your PlexusDx provider can discuss which delivery method aligns best with your goals and daily routine.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose with semaglutide?
Average weight loss ranges from 15-22% of your starting body weight over 12-16 weeks at therapeutic doses, based on STEP trial data. Individual results vary based on dose, adherence, diet, and exercise, with some patients losing 30+ pounds while others lose 10-15 pounds.
How long does it take to see results from semaglutide?
Most patients notice reduced appetite and early weight loss within 2-4 weeks of starting treatment, with measurable scale changes appearing by week 6-8. Significant weight loss typically accelerates after 8-12 weeks as your dose reaches therapeutic levels.
What is PlexusDx's pricing and how does insurance work?
PlexusDx compounded semaglutide injection starts at $149 per month with no insurance required, no membership fees, and service to all 50 states. Treatment is HSA/FSA eligible, meaning eligible healthcare spending accounts can cover your medications.
Can I stop taking semaglutide and keep the weight off?
Clinical data shows that most patients gradually regain weight if they discontinue semaglutide, though weight regain is typically slower than the original weight loss. Semaglutide works best as an ongoing maintenance therapy combined with sustained dietary and lifestyle improvements.
How does the Precision Peptide Genetic Test help with semaglutide therapy?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R rs6923761, GIPR rs1800437, FTO, and MC4R variants across 14 metabolic pathways to predict your individual response and side effect risk.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Can You Lose on Semaglutide? A Comprehensive Review
What is the Best Injection Site for Semaglutide?